A new company is making its debut with a series A sum that’s sure to make hearts race. | A new company is making its debut ...
Norm has received breakthrough device designation from the Food and Drug Administration, giving Fire1 additional access to ...
After the successful development of mavacamten and the sale of MyoKardia to BMS in 2020, former executives of the biotech are ...
High-resolution of cellular heterogeneity from the molecular to circuit level reveals the molecular logic driving cellular ...
Selbyville, Delaware, Jan. 08, 2025 (GLOBE NEWSWIRE) -- ...
Using computers to make a digital replica of the heart—a digital heart twin—can successfully identify problem areas deep in ...
Download the revised NEET UG Biology Syllabus along with important topics, exam pattern and marks distribution. Know the ...
Back in June 2020, Shanghai-based Corxel—at the time known as Ji Xing—gained aficamten rights in China across indications tied to excessive heart contractility. Then, earlier this month ...
In August, a single email triggered a chain of hand-wringing and strategizing inside one of America’s largest medical technology companies: A reporter asked Boston Scientific if the biotech ...
CHICAGO — Over the years, a handful of cities have tried catching up to the flourishing biotech hubs in Boston or the San Francisco Bay … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback